November 19, 2012
Many of us who live with HIV are alive today in part because we received effective treatment to clear our hepatitis C (HCV) co-infections. Interferon-boosted Ribavirin was a lifesaver, but the interferon side effects could be rugged.
MedPage Today reports that a triple-drug regimen without interferon has been found in a small study to be highly effective in clearing even treatment-resistant HCV genotype 1. FDA approval for clinical use is still a long way off, but we look forward to a future of effective HCV treatment without interferon.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|The Future of 2-Drug Regimens for People With HIV|
|Do People With HIV Need Annual Physical Examinations?|
|Liquor Tied to Gut Integrity and Inflammation in Adults With HIV|
|Expert: Long-Awaited CDC HIV Report on Conception Options for Serodiscordant Couples Is Disappointing and Confusing|
|Canadian Study Finds Increased Risk of Death Among HIV-Positive Indigenous People|
|This Week in HIV Research: Early Treatment With Broadly Neutralizing Antibodies Suppresses SHIV in Monkeys|